Information barriers to the implementation of economic evaluations in Japan

Shuzo Nishimura, George W. Torrance, Naoki Ikegami, Shunichi Fukuhara, Michael Drummond, François Schubert

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and resources. Facing similar pressures, Japan will probably also introduce economic evaluation of health technology. However, the structure of the healthcare system in Japan does not lend itself naturally to the collection of the epidemiological and cost data required for economic evaluations in medicine. In addition, there are no formal methodological guidelines in place for these analyses. To overcome these information barriers in Japan, progress may be aided by the adoption of approaches used in other countries for data collection and guideline development.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalPharmacoEconomics
Volume20
Issue numberSUPPL. 2
Publication statusPublished - 2002

Fingerprint

Cost-Benefit Analysis
Japan
Pharmaceutical Technology
Guidelines
Delivery of Health Care
Pressure
Biomedical Technology
Resource Allocation
Cost Control
Health Expenditures
Medicine
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pharmacology
  • Medicine (miscellaneous)

Cite this

Nishimura, S., Torrance, G. W., Ikegami, N., Fukuhara, S., Drummond, M., & Schubert, F. (2002). Information barriers to the implementation of economic evaluations in Japan. PharmacoEconomics, 20(SUPPL. 2), 9-15.

Information barriers to the implementation of economic evaluations in Japan. / Nishimura, Shuzo; Torrance, George W.; Ikegami, Naoki; Fukuhara, Shunichi; Drummond, Michael; Schubert, François.

In: PharmacoEconomics, Vol. 20, No. SUPPL. 2, 2002, p. 9-15.

Research output: Contribution to journalArticle

Nishimura, S, Torrance, GW, Ikegami, N, Fukuhara, S, Drummond, M & Schubert, F 2002, 'Information barriers to the implementation of economic evaluations in Japan', PharmacoEconomics, vol. 20, no. SUPPL. 2, pp. 9-15.
Nishimura S, Torrance GW, Ikegami N, Fukuhara S, Drummond M, Schubert F. Information barriers to the implementation of economic evaluations in Japan. PharmacoEconomics. 2002;20(SUPPL. 2):9-15.
Nishimura, Shuzo ; Torrance, George W. ; Ikegami, Naoki ; Fukuhara, Shunichi ; Drummond, Michael ; Schubert, François. / Information barriers to the implementation of economic evaluations in Japan. In: PharmacoEconomics. 2002 ; Vol. 20, No. SUPPL. 2. pp. 9-15.
@article{4f00e8a9c124421cbc73fc0c177f6e05,
title = "Information barriers to the implementation of economic evaluations in Japan",
abstract = "With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and resources. Facing similar pressures, Japan will probably also introduce economic evaluation of health technology. However, the structure of the healthcare system in Japan does not lend itself naturally to the collection of the epidemiological and cost data required for economic evaluations in medicine. In addition, there are no formal methodological guidelines in place for these analyses. To overcome these information barriers in Japan, progress may be aided by the adoption of approaches used in other countries for data collection and guideline development.",
author = "Shuzo Nishimura and Torrance, {George W.} and Naoki Ikegami and Shunichi Fukuhara and Michael Drummond and Fran{\cc}ois Schubert",
year = "2002",
language = "English",
volume = "20",
pages = "9--15",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Information barriers to the implementation of economic evaluations in Japan

AU - Nishimura, Shuzo

AU - Torrance, George W.

AU - Ikegami, Naoki

AU - Fukuhara, Shunichi

AU - Drummond, Michael

AU - Schubert, François

PY - 2002

Y1 - 2002

N2 - With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and resources. Facing similar pressures, Japan will probably also introduce economic evaluation of health technology. However, the structure of the healthcare system in Japan does not lend itself naturally to the collection of the epidemiological and cost data required for economic evaluations in medicine. In addition, there are no formal methodological guidelines in place for these analyses. To overcome these information barriers in Japan, progress may be aided by the adoption of approaches used in other countries for data collection and guideline development.

AB - With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and resources. Facing similar pressures, Japan will probably also introduce economic evaluation of health technology. However, the structure of the healthcare system in Japan does not lend itself naturally to the collection of the epidemiological and cost data required for economic evaluations in medicine. In addition, there are no formal methodological guidelines in place for these analyses. To overcome these information barriers in Japan, progress may be aided by the adoption of approaches used in other countries for data collection and guideline development.

UR - http://www.scopus.com/inward/record.url?scp=0036377674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036377674&partnerID=8YFLogxK

M3 - Article

C2 - 12238944

AN - SCOPUS:0036377674

VL - 20

SP - 9

EP - 15

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - SUPPL. 2

ER -